Abbott Laboratories

2026-10-09 22:01; UTC

Abbott Laboratories shares advanced in after-market trading, reflecting a modest increase since Friday's close while fluctuating around the middle of its one-month range.

2026-10-08 22:45; UTC

Abbott Laboratories shares are trading lower in after-market hours, remaining below their 20-day moving average and near the lower end of their one-month range.

2026-10-07 23:50; UTC

Abbott Laboratories is trading slightly higher in after-market hours, following a modest earlier session increase, though it remains below its 20-day moving average.

2026-10-06 20:07; UTC

Abbott Laboratories shares fell sharply after an earlier rise, reaching their lowest point of the day and remaining below the 20-day moving average.

2026-10-05 23:05; UTC

Abbott Laboratories is trading slightly higher in after-market hours, while the S&P Global Composite PMI rose to 58.4, indicating strong growth in the U.S. economy.

2026-10-02 20:07; UTC

Abbott Laboratories upgraded to Buy from Hold by Rothschild & Co Redburn, with a price target increase to $127, as shares trade modestly higher.

2026-10-01 20:07; UTC

Abbott Laboratories shares fell sharply, closing at their lowest point for the session and trading well below the 20-day moving average.

2026-09-30 20:07; UTC

Abbott Laboratories launched SimpleScreen CRC, an FDA-approved blood test for colorectal cancer, but shares fell amid broader market trends.

2026-09-29 23:00; UTC

Abbott Laboratories is declining in after-market trading, finishing lower for three consecutive sessions and positioned significantly below its 20-day moving average.

2026-09-25 20:07; UTC

Abbott Laboratories' shares are higher amid a broader market rally, recovering from an earlier pullback but still below its 20-day moving average.

2026-09-24 19:51; UTC

Abbott Laboratories shares fell, diverging from recent gains, amid a report showing a slight improvement in U.S. Jobless Claims' 4-week Average.

2026-09-23 20:01; UTC

Abbott Laboratories announced a partnership with Berry Street for personalized nutrition support, but shares fell amid broader market reactions to insider trading activity.

2026-09-22 23:41; UTC

Abbott Laboratories is seeing a modest increase in after-market trading, following three consecutive higher daily closes despite being below its 20-day moving average.

2026-09-21 23:00; UTC

Abbott Laboratories is trading modestly higher in after-market hours, recovering from earlier declines but remains below its 20-day moving average.

2026-09-16 19:16; UTC

Abbott Laboratories shares are modestly higher but remain below their 20-day moving average and near the lower end of their one-month range.

2026-09-15 23:01; UTC

Abbott Laboratories shares are higher in after-market hours, reflecting broader market trends. No specific company news was identified to explain the movement.

2026-09-14 22:51; UTC

Abbott Laboratories shares are lower in after-market hours, reflecting broader market declines amid rising crude oil prices due to geopolitical supply concerns.

2026-09-12 00:01; UTC

Abbott Laboratories shares are higher in after-market trading, despite being below the 20-day moving average and a trend of lower closes.

2026-09-11 23:01; UTC

Abbott Laboratories shares are higher in after-market trading, settling at a cumulative return of 1.60%. The U.S. budget deficit for August was $167 billion.

2026-09-10 19:16; UTC

Abbott Laboratories received FDA approval for its TactiFlex Duo catheter. Shares are lower today, continuing a trend of declining prices over the past week.

2026-09-09 23:26; UTC

Abbott Laboratories received U.S. FDA approval for its TactiFlex Duo ablation catheter. Shares are higher in after-market trading, reflecting a recovery from recent declines.

2026-09-08 20:02; UTC

Abbott Laboratories shares are lower, reaching a four-week low of $106.72 amid weakness in the Health Care Equipment sector despite FDA approval for its ablation catheter.

2026-09-04 20:07; UTC

Abbott Laboratories shares are lower, influenced by a strong jobs report that increased selling pressure across risk assets. The stock remains near its one-month trading range low.

2026-09-03 23:31; UTC

Abbott Laboratories shares declined in after-market trading, reflecting ongoing weakness. The stock is near the lower end of its one-month range.

2026-09-02 23:56; UTC

Abbott Laboratories shares are lower in after-market hours, reflecting a decline since Wednesday's close amid weaker-than-expected job growth reported by ADP.

2026-09-01 23:51; UTC

Abbott Laboratories shares are higher in after-market hours amid notable trading activity. Rising oil prices and inflation concerns may influence Federal Reserve policy decisions.

2026-08-31 23:32; UTC

Abbott Laboratories sees gains in after-market trading, reflecting strength in the health care equipment sector and broader positive trends among correlated assets.

2026-08-28 23:16; UTC

Abbott Laboratories shares are higher in after-market hours, following a modest gain earlier, alongside Medtronic PLC's advance in the health care equipment sector.

2026-08-27 22:51; UTC

Abbott Laboratories shares are trading higher in after-market hours, reversing three consecutive daily declines. No specific news was identified to explain the movement.

2026-08-26 23:21; UTC

Abbott Laboratories is higher in after-market hours, reflecting broader market gains. The stock remains above its 20-day moving average despite recent fluctuations.